Molbio Diagnosti

  • Market Cap: Mid Cap
  • Industry: Healthcare Services
  • ISIN: INE869T01028
  • NSEID: MOLBIO
  • BSEID: 544866
INR
1,495.00
-32.15 (-2.11%)
BSENSE

Nov 20

BSE+NSE Vol: 67962

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Sep'25
Jun'25
Net Sales
259.02
408.38
560.62
580.27
99.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
259.02
408.38
560.62
580.27
99.71
Raw Material Cost
113.00
131.47
241.98
178.64
77.94
Purchase of Finished goods
3.47
6.26
0.92
3.51
0.67
(Increase) / Decrease In Stocks
-17.07
11.95
-7.51
40.30
-43.44
Employee Cost
37.80
45.92
45.92
33.88
28.18
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
77.87
112.19
120.59
155.75
51.61
Total Expenditure (Excl Depreciation)
215.07
307.79
401.90
412.08
114.96
Operating Profit (PBDIT) excl Other Income
43.95
100.59
158.72
168.19
-15.25
Other Income
5.77
3.10
4.79
1.09
0.76
Operating Profit (PBDIT)
49.72
103.69
163.51
169.28
-14.49
Interest
8.86
10.70
12.08
6.98
3.61
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
40.86
92.99
151.43
162.30
-18.10
Depreciation
23.36
17.08
19.60
13.81
12.32
Profit Before Tax
17.51
75.91
131.83
147.74
-31.28
Tax
9.80
23.17
36.00
40.90
-7.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
7.70
52.74
95.83
107.60
-23.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
7.70
52.74
95.83
107.60
-23.09
Share in Profit of Associates
0.00
0.00
0.00
-0.76
-0.85
Minority Interest
-7.42
-6.00
5.00
-2.96
-0.23
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
15.12
58.75
90.83
109.80
-23.71
Equity Capital
11.52
11.28
11.28
11.28
2.26
Face Value
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
1.31
5.21
8.05
9.73
-10.49
Diluted Earnings per share
1.33
5.21
8.05
9.74
-2.1
Operating Profit Margin (Excl OI)
16.97%
24.63%
28.31%
28.98%
-15.29%
Gross Profit Margin
15.77%
22.77%
27.01%
27.97%
-18.15%
PAT Margin
2.97%
12.91%
17.09%
18.41%
-24.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is -37.68% vs -8.96% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is -44.59% vs -13.79% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is -36.01% vs -14.39% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -27.60% vs -6.68% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Molbio Diagnosti With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
259.02
832.70
-573.68
-68.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
259.02
832.70
-573.68
-68.89%
Raw Material Cost
113.00
203.00
-90.00
-44.33%
Purchase of Finished goods
3.47
0.00
3.47
(Increase) / Decrease In Stocks
-17.07
-4.40
-12.67
-287.95%
Employee Cost
37.80
272.70
-234.90
-86.14%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
77.87
214.00
-136.13
-63.61%
Total Expenditure (Excl Depreciation)
215.07
685.30
-470.23
-68.62%
Operating Profit (PBDIT) excl Other Income
43.95
147.40
-103.45
-70.18%
Other Income
5.77
28.00
-22.23
-79.39%
Operating Profit (PBDIT)
49.72
175.40
-125.68
-71.65%
Interest
8.86
10.00
-1.14
-11.40%
Exceptional Items
0.00
-6.70
6.70
100.00%
Gross Profit (PBDT)
40.86
158.70
-117.84
-74.25%
Depreciation
23.36
111.70
-88.34
-79.09%
Profit Before Tax
17.51
47.00
-29.49
-62.74%
Tax
9.80
14.80
-5.00
-33.78%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
7.70
32.20
-24.50
-76.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
7.70
32.20
-24.50
-76.09%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-7.42
0.00
-7.42
Other related items
0.00
0.00
0.00
Consolidated Net Profit
15.12
32.20
-17.08
-53.04%
Equity Capital
11.52
403.70
-392.18
-97.15%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
1.31
0.80
0.51
63.75%
Diluted Earnings per share
1.33
0.80
0.53
66.25%
Operating Profit Margin (Excl OI)
16.97%
17.70%
0.00
-0.73%
Gross Profit Margin
15.77%
19.06%
0.00
-3.29%
PAT Margin
2.97%
3.87%
0.00
-0.90%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 248.88 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -37.68% vs -8.96% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -57.04%

Quarterly - Standalone Net Profit
Standalone Net Profit 31.38 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -44.59% vs -13.79% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -65.88%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.64 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -36.01% vs -14.39% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -56.32%

Quarterly - Interest
Interest 6.27 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -27.60% vs -6.68% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 60.36%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.56%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025